Automated Plaque Quantification in CCTA Scans

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing coronary artery plaques in CCTA scans are limited by the need for manual tracing and are prone to variability, lacking standardized and automated quantification of non-calcified and calcified components, which is crucial for accurate cardiovascular risk assessment.

Innovation Solution

A computer-implemented method that uses CCTA scan data to determine attenuation thresholds and classify components, automatically identifying non-calcified and calcified plaque volumes by generating centerlines, detecting epicardial fat, and segmenting the coronary artery, thereby providing standardized and reproducible quantification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual tracing methods are used to analyze plaque components, then flexibility in analysis is maintained, but processing time increases and measurement precision deteriorates due to variability

Engineering Contradiction:
Improveplaque component quantification accuracyVSAvoidmanual processing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces manual mechanical tracing operations with an automated computer-based system that uses algorithmic processing of CT scan data. The system automatically identifies and quantifies non-calcified and calcified plaque components through computational analysis, eliminating manual intervention while maintaining measurement precision and reducing processing time.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system performs self-service by automatically generating its own analysis results without requiring manual operator input for each measurement. The automated algorithm processes the CT scan data independently, producing standardized quantification of plaque components that is consistent and reproducible across different analyses.

Inventive Principle:
Principle #25Self-service

2Reliability

If manual tracing is used for plaque analysis, then adaptability to different cases is maintained, but reliability deteriorates due to operator variability

Engineering Contradiction:
Improvemeasurement consistencyVSAvoidautomation system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs parameter changes by adjusting attenuation thresholds dynamically based on the specific characteristics of each CT scan and patient case. The system modifies measurement parameters adaptively to accommodate different plaque types, contrast conditions, and imaging protocols, ensuring reliable and consistent quantification across diverse clinical scenarios while maintaining measurement accuracy.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If automated threshold determination is implemented, then productivity increases, but measurement precision may worsen if thresholds are not accurately calibrated

Engineering Contradiction:
Improveprocessing speedVSAvoidthreshold accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The system incorporates feedback mechanisms that continuously monitor and adjust attenuation threshold values based on the actual CT scan data characteristics. The automated algorithm analyzes the scan images and modifies threshold parameters in real-time to maintain optimal separation between different tissue densities, ensuring both high productivity through automation and precise measurement through adaptive calibration.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS8885905B2Method and system for plaque characterization
Publication Date: 2014.11.11 CEDARS SINAI MEDICAL CENT
  • US8885905B2 patent drawing
  • US8885905B2 patent drawing
  • US8885905B2 patent drawing

AI summary

A method of quantifying plaques imaged by cardiac computed tomography angiography (“CCTA”) scan data. Calcified and non-calcified component thresholds are determined based at least in part on attenuation values of a pool of blood in the CCTA scan data. An epicardial fat threshold is determined and used to classify epicardial fat in the CCTA scan data. A portion of CCTA scan data positioned between a detected outer boundary of the coronary artery and a portion classified as lumen is classified as arterial wall. NCP and CP seeds are identified in the arterial wall portion. Portions of the CCTA scan data continuous with a NCP seed and having attenuation values greater than an artery wall value and less than the NCP threshold are classified as NCP, and portions of the CCTA scan data continuous with the CP seed and having attenuation values greater than the CP threshold are classified as CP.